Categories: News

Stavian Chemical Climbs to Top 15 in ICIS Top 100 Global Chemical Distributors 2025

HANOI, Vietnam, June 16, 2025 /PRNewswire/ — Stavian Chemical, a leading global chemical distributor and manufacturer, proudly announces its advancement to 15th place in the prestigious ICIS Top 100 Global Chemical Distributors 2025 ranking, up from 17th in 2024. The company also maintains its stronghold as one of the Top 7 distributors in the Asia-Pacific (APAC) region, reinforcing its strategic influence and operational excellence across global markets.

- Advertisement -

This significant leap reflects Stavian Chemical’s unwavering commitment to innovation, sustainability, and customer-centric solutions in the chemical distribution industry. The ICIS ranking, recognized as the industry benchmark, evaluates companies based on sales performance, global reach, and strategic growth.

- Advertisement -

We are honored to be recognized once again by ICIS and to see our efforts reflected in this year’s rankings,” said Mr. Dinh Duc Thang, Chairman and CEO of Stavian Chemical. “This achievement is a testament to the dedication of our global team, the trust of our partners, and our relentless pursuit of excellence in delivering sustainable chemical solutions worldwide.”

- Advertisement -

Over the past year, Stavian Chemical has expanded its global footprint, enhanced its digital transformation initiatives, and strengthened its ESG commitments. These strategic moves have positioned the company as a key player in shaping the future of the global chemical supply chain.

- Advertisement -

As Stavian Chemical continues to grow, it remains focused on delivering value to its stakeholders while contributing to a more sustainable and resilient global economy.

- Advertisement -

About Stavian Chemical

- Advertisement -

Founded in 2009 and headquartered in Hanoi, Vietnam, Stavian Chemical is the flagship subsidiary of Stavian Group, a multinational corporation operating across technology, industry, and international trade. As a global leader in chemical distribution and a top-tier manufacturer of packaging, Stavian Chemical delivers a comprehensive “One-Stop Shop” solution, seamlessly connecting clients through its international network of offices and warehouses. With a proven track record of excellence and numerous industry accolades, Stavian Chemical remains at the forefront of innovation, committed to providing integrated, end-to-end services to partners across both regional and global markets.

- Advertisement -

For more information on Stavian Chemical, please visit: https://stavianchem.com/

- Advertisement -

Photo – https://mma.prnewswire.com/media/2711140/Press_Release___Stavian_Chemical_Top_15_ICIS_2025.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/stavian-chemical-climbs-to-top-15-in-icis-top-100-global-chemical-distributors-2025-302481862.html

- Advertisement -

Recent Posts

Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment

Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…

51 minutes ago

Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026

New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…

51 minutes ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…

2 hours ago

Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders

BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…

2 hours ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…

2 hours ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…

2 hours ago